Cargando…
TRPM4 in Cancer—A New Potential Drug Target
Transient receptor potential melastatin 4 (TRPM4) is widely expressed in various organs and associated with cardiovascular and immune diseases. Lately, the interest in studies on TRPM4 in cancer has increased. Thus far, TRPM4 has been investigated in diffuse large B-cell lymphoma, prostate, colorect...
Autores principales: | Borgström, Anna, Peinelt, Christine, Stokłosa, Paulina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914809/ https://www.ncbi.nlm.nih.gov/pubmed/33562811 http://dx.doi.org/10.3390/biom11020229 |
Ejemplares similares
-
Investigation of Novel Small Molecular TRPM4 Inhibitors in Colorectal Cancer Cells
por: Stokłosa, Paulina, et al.
Publicado: (2021) -
A Novel Role of the TRPM4 Ion Channel in Exocytosis
por: Stokłosa, Paulina, et al.
Publicado: (2022) -
TRP Channels in Digestive Tract Cancers
por: Stokłosa, Paulina, et al.
Publicado: (2020) -
TRPM4 is highly expressed in human colorectal tumor buds and contributes to proliferation, cell cycle, and invasion of colorectal cancer cells
por: Kappel, Sven, et al.
Publicado: (2019) -
Store-Operated Ca(2+) Entry as a Prostate Cancer Biomarker — a Riddle with Perspectives
por: Kappel, Sven, et al.
Publicado: (2017)